← Guides & comparisons

Guide / THE TONE DESK

Ingredient percentages are not a skincare ranking

Read concentration alongside the complete preparation, the care route and the outcome being claimed.

A percentage is easy to compare on a screen. What it means is harder: the number may identify one ingredient in a fixed product, one possible ingredient in a prescribing menu or a marketing highlight without the rest of the formula.

Keeping those categories visible is more useful than treating the highest number as the best option. This guide explains how to read a product record without selecting a strength, combining products or drawing conclusions about your skin.

Guide. Start with the entire product name. The base is part of the record
Guide: keep the named record and its context together.

Start with the entire product name

A concentration identifies one part of a preparation. It does not independently establish the best choice, a result or a safe combination for an individual.

Obagi’s prescription Nu-Derm Clear and retail Clear Fx illustrate the problem with names. The prescription record identifies hydroquinone; the similarly named retail product has a different formula and purchase route. A price or testimonial from one cannot fill a missing fact about the other. Read the Obagi review with both manufacturer records in view. Prescription record Retail record

A menu is not the prescription

Musely lists several possible Spot Cream formulas and reserves prescribing decisions to the clinician. A menu therefore describes possibilities rather than a guaranteed combination. Agency likewise distinguishes hydroquinone-containing and hydroquinone-free preparations. Musely formula information Agency product

The useful question is which exact formula is proposed and why. It is not necessary to turn an educational comparison into a request for the strongest combination. Concentration, vehicle, other ingredients, the concern being assessed and professional monitoring are not interchangeable details.

The base is part of the record

An active highlight leaves out the rest of the preparation. Published inactive lists can help identify a product, but they cannot determine an individual’s tolerance or authenticate a supplied container. For medicines, the prescriber and pharmacist can address the actual prescription and label. FDA pharmacist information

Keep the version and date of a list when asking about an apparent difference. A reformulated retail serum and an older ingredient photograph can both be real records of different products. Our formula-change guide explains how to keep that history readable.

READING NOTE. The base is part of the record. Keep the source in view
Reading note: the base is part of the record. Original editorial illustration.

Evidence must match the outcome

A manufacturer’s ingredient explanation, consumer survey and controlled study are different kinds of support. Evidence about hydration or texture cannot silently become evidence of a particular pigment condition. FTC guidance emphasizes matching substantiation to the actual claim. Advertising evidence guidance

In the comparison desk, the evidence view retains a limitation rather than assigning clinical points to a concentration. It is a tool for reading two records, not calculating which medicine will work better.

Bring the unresolved detail to the right person

For a medicine question, identify the exact preparation before asking whether a label and website description differ. For a question about the cause of a mark, product research is not a substitute for assessment. AAD explains that a dermatologist may need examination and other information to distinguish melasma from other conditions. AAD guidance

A concise question can keep the two tasks separate: which product is this, and what clinical question would need to be answered before discussing it? The care-context page offers examples without collecting a health history.

Follow the source trail.

Published descriptions are not firsthand testing of care, fulfillment or individual outcomes.

  1. Obagi Nu-Derm Clear prescription cream — official product ↗Current manufacturer or professional-service description · Accessed 2026-10-05
  2. Obagi Nu-Derm Clear prescription cream — official context ↗Current manufacturer or professional-service description · Accessed 2026-10-05
  3. Musely: What are the formulas of The Spot Cream? ↗Provider formula help record · Accessed 2026-10-05
  4. Agency Dark Spot Rx — official product ↗Current manufacturer or professional-service description · Accessed 2026-10-05
  5. FDA: Pharmacists Help You Use Medicines Safely ↗Official medicine-history, pharmacy-question and conflicting-information guidance; no individual compatibility decision · Accessed 2026-10-05
  6. FTC: Health Products Compliance Guidance ↗Advertising imagery and matching evidence to the actual product and claim; not a photographic diagnosis or authentication method · Accessed 2026-10-05
  7. AAD: Melasma diagnosis and treatment ↗Professional association patient information · Accessed 2026-10-05
Open the complete source register